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AbstrACt
background As infectious diseases approach global 
elimination targets, spatial targeting is increasingly 
important to identify community hotspots of transmission 
and effectively target interventions. We aimed to 
synthesise relevant evidence to define best practice 
approaches and identify policy and research gaps.
Objective To systematically appraise evidence for the 
effectiveness of spatially targeted community public 
health interventions for HIV, tuberculosis (TB), leprosy and 
malaria.
Design Systematic review.
Data sources We searched Medline, Embase, Global 
Health, Web of Science and Cochrane Database of 
Systematic Reviews between 1 January 1993 and 22 
March 2021.
study selection The studies had to include HIV or TB 
or leprosy or malaria and spatial hotspot definition, and 
community interventions.
Data extraction and synthesis A data extraction tool 
was used. For each study, we summarised approaches to 
identifying hotpots, intervention design and effectiveness 
of the intervention.
results Ten studies, including one cluster randomised 
trial and nine with alternative designs (before–after, 
comparator area), satisfied our inclusion criteria. Spatially 
targeted interventions for HIV (one USA study), TB (three 
USA) and leprosy (two Brazil, one Federated States of 
Micronesia) each used household location and disease 
density to define hotspots followed by community- based 
screening. Malaria studies (one each from India, Indonesia 
and Kenya) used household location and disease density 
for hotspot identification followed by complex interventions 
typically combining community screening, larviciding of 
stagnant water bodies, indoor residual spraying and mass 
drug administration. Evidence of effect was mixed.
Conclusions Studies investigating spatially targeted 
interventions were few in number, and mostly 
underpowered or otherwise limited methodologically, 
affecting interpretation of intervention impact. Applying 
advanced epidemiological methodologies supporting more 
robust hotspot identification and larger or more intensive 
interventions would strengthen the evidence- base for this 
increasingly important approach.
PrOsPErO registration number CRD42019130133.
IntrODuCtIOn
The world has made tremendous strides in 
controlling HIV, tuberculosis (TB), leprosy 
and malaria epidemics. Despite impressive 
achievements in reductions of new cases, 
considerable efforts are required to meet and 
maintain elimination targets.1–4 Much of the 
current progress in disease control is attrib-
utable to the combination of facility based 
routine health services, supplemented by 
community based interventions.1–4
The success of disease control strategies 
provided through facility- based services relies 
on prompt recognition of symptoms by the 
patient, early health seeking by the patient, 
and correct recognition and management 
by health providers to provide early diag-
nosis and effective medical care.1–4 However, 
health- seeking delays can be prolonged, and 
this strategy will also have no effect on trans-
mission during subclinical illness.2 5–7 In low- 
income settings, lack of faith in the quality of 
services, high opportunity and indirect costs 
strengths and limitations of this study
 ► This was a thoroughly conducted systematic review 
which only included published literature.
 ► We developed the search strategy with input from 
infectious disease experts, statisticians and librari-
ans, and we only included studies that met our ob-
jective assessment criteria.
 ► We acknowledge that some studies might still have 
been missed even with the systematic approach 
that we used.
 ► The effect of publication bias cannot be ruled out as 
it is possible that studies that had negative results 
might not have been published; thereby, they would 
not have been captured by our search strategy.
 ► The studies had different interventions and out-
comes as such a meta- analysis was not done con-
trary to the initial plans.
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and non- adherence to syndromic management proto-
cols can combine to cause substantial health- seeking 
and diagnostic delays, undermining the effectiveness of 
facility- based strategies based on early diagnosis and treat-
ment.2 4 5 8–12 Community interventions can be comple-
mentary to facility- based services but are more resource 
intensive, logistically challenging and are generally only 
justifiable when targeted at groups of people at risk or 
in a geographically defined area with high prevalence or 
incidence of disease.1–4
In communities, HIV, TB, leprosy and malaria cluster 
geographically into hotspots.13–19 Hotspots are defined 
as areas of high incidence or prevalence compared with 
neighbouring geographical areas.20 For malaria, which is 
vector- borne, environmental characteristics conducive to 
replication of anopheles mosquitos are a key consider-
ation.18 For HIV, TB and leprosy, diseases that are trans-
mitted exclusively person- to- person, hotspots tend to be 
characterised by poverty, poor access to health services, 
overcrowding, concentrations of migrant populations, 
and poor housing.13–18 Since hotspots are likely to be 
areas of relatively high transmission, targeting interven-
tions at hotspots may prevent many more infections and 
cases of disease than similar efforts in low- transmission 
settings or untargeted efforts (online supplemental 
figure 1).21 Public health interventions amenable to 
spatially defined hotspot targeting include: screening, 
case- finding, prevention (including vaccination), and 
improvement in access to services for diagnosis and treat-
ment.15 20
Community health and prevention interventions 
frequently target people in slums or informal urban 
settlements.22 In low and middle income countries, 
many millions of people live in informal urban settle-
ments,23 and disease control programmes would benefit 
from more precise identification of high priority areas 
within these to allow interventions to be delivered to 
communities where the impact is likely to be greatest.24 25 
At the moment targeting tends to use relatively crude 
epidemiological criteria such as age and gender.1–4 26 
But since cases of the diseases in this review are known 
to cluster geographically, targeting of all people in a 
carefully identified geographically defined hotspots 
offers an alternative criteria to define at- risk groups for 
interventions.13–19
The main aim of this systematic review was to system-
atically appraise evidence for spatially targeted commu-
nity public health interventions directed towards major 
infectious diseases that are transmitted in different ways: 
HIV is predominantly sexually transmitted; TB by respi-
ratory droplet transmission; leprosy by direct contact and 
droplet transmission; and malaria by vector- borne trans-
mission. We aimed to summarise lessons learnt from eval-
uation of spatially targeted interventions against these 
diseases and to make recommendations for researchers, 
policymakers and disease control programmes, as well 
as to inform the design and evaluation of future studies 





We developed the research question for this project after 
realising the evidence gap on the effectiveness of spatially 
targeted interventions despite the growing interest that 
this approach has. To develop the scope of the research 
question we engaged experts in public health interven-
tions of HIV, TB, leprosy and malaria. The search strategy 
was also developed in consultation with the experts. The 
results of the research will be disseminated to researchers 
and policy- makers at local and international conferences.
search strategy
We systematically searched the literature using major 
subject headings and keywords to identify published 
studies meeting the inclusion criteria following our 
published protocol (PROSPERO ID: CRD42019130133). 
Databases searched included: Medline, Embase, Global 
Health, Web of Science and the Cochrane Database of 
Systematic Reviews. The three central concepts included 
in our search strategy (online supplemental table 1) were 
the disease condition (HIV, TB, leprosy and malaria); 
space (techniques used to identify hotspots); and commu-
nity interventions.
Eligibility criteria
We included studies published between the period from 
1 January 1993 and 22 July 2019 and then updated to 22 
March 2021. The start of the search period was chosen 
as the year that TB was declared as a ‘global emergency’ 
by the WHO. We focused on studies of spatially targeted 
interventions for HIV, TB, leprosy and malaria with the 
aim of identifying all the available literature on the effec-
tiveness of spatially targeted intervention in the selected 
diseases, and then summarising the findings. We did not 
limit inclusion by age group of participants or geograph-
ical region. We included randomised controlled trials, 
non- randomised observational studies, before- and- after 
studies and time- series analysis studies. The following 
articles were excluded: editorials; narratives; systematic 
reviews; case studies; case reports; case- control studies; 
contact investigation studies; and non- spatially targeted 
community studies.
selection of studies and data extraction
We imported studies into an Endnote (Thompsons 
Reuters) database, and duplicates were removed. MK and 
MN independently screened the title and abstracts against 
inclusion and exclusion criteria (online supplemental 
table 2), identified studies eligible for full- text review, and 
subsequently reviewed the full text of each selected study 
independently. Discrepancies between MK and MN were 
resolved with discussion, and where agreement could not 
be reached, two other reviewers (PMP and JRC) partici-
pated in a consensus review.
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We developed a data extraction form that was piloted 
on a sample of selected manuscripts. This form was inde-
pendently completed for each study selected for full- text 
review by MK and MN.
Assessment of study quality
Two reviewers (MK and MN) assessed the quality of each 
study. We used separate tools to assess the methodological 
quality of cluster randomised trials (CRTs) (Cochrane 
Collaboration risk of bias tool)27 and non- randomised 
studies (ROBINS- I: a tool for assessing risk of bias in non- 
randomised studies of interventions).28
Definitions
We defined spatially targeted interventions as community 
interventions that targeted hotspots of disease. Hotspots 
were defined as subdistrict geospatially defined areas that 
had a high number of incident or prevalent cases of the 
infection or disease compared with surrounding areas, 
studies that based their hotspots as around diagnosed 
index cases were not included. In practice, as definitions 
varied considerably between studies, we extracted and 
compared hotspot definitions between studies.
statistical analysis
The main objective of the systematic review was to 
compare the impact of the intervention in the inter-
vention hotspot areas compared with control areas. We 
report the outcomes defined by the included studies, with 
outcomes being prevalence, incidence, case notification 
rates and number needed to screen to identify a positive 
case. We calculated measures of effect and uncertainty in 
effect estimates using data available in manuscripts where 
these were not provided by the authors using R V.3.61 (R 
Core Team). Because of high anticipated heterogeneity 
between and within diseases and interventions investi-
gated, we decided not to undertake meta- analysis.
Ethics statement
This review used published data, and ethical review was 
not required.
Data sharing statement
The search strategy and summary data tables for this 
systematic review have all been included in the main text 
and in the appendix section.
rEsults
A total of 3919 unique abstracts were identified by the 
search strategy, from which 3886 were excluded from 
the title and abstract review, leaving 28 studies that were 
reviewed as full- text articles. Overall, 10 studies met the 
inclusion criteria (online supplemental figure 2). The 
reasons for exclusion are found in online supplemental 
table 2.
One USA- based study was identified for HIV. Three TB 
studies were found: all three studies were from the USA. 
Three leprosy studies were found: two from Brazil and 
one study from the Federated States of Micronesia. For 
malaria, we identified three studies: one each from India, 
Indonesia and Kenya. The most common study design 
was implementation demonstration studies (ie, studies 
in which spatially targeted interventions were introduced 
without random allocation of hotspots to study arms). 
Nine studies had this design: one HIV, three TB, three 
leprosy and two malaria. We identified one CRT, which 
evaluated interventions targeted against malaria (online 
supplemental table 3).
Table 1 summarises the characteristics of the included 
studies, presenting outcomes, measures of intervention 
effects and study quality/risk of bias assessment results. 
Table 2 synthesises methods used to geolocate cases and 
identify hotspots in the included studies. 10 Online supple-
mental table 3 has details on why studies were excluded 
following full text review.
spatially targeted hIV interventions
In Goswami et al,29 cases of TB (N=150), HIV (N=665) 
and syphilis (N=155) notified between 1 January 2005 
and 31 December 2007 in Wake County, North Carolina, 
USA, were geocoded to households. Kernel density maps 
of the three diseases were generated; maps identified 
two areas with the densest number of cases (hotspots). 
Hotspots were defined as areas with more than 10 cases of 
either TB, HIV or syphilis notified per square mile during 
the 3 years. A map of streets and local businesses of Wake 
County was used to identify the locations of the hotspot 
areas.
Between 2 June 2009 and 3 November 2011, adult 
community screening for HIV was done in the defined 
hotspots at specific sites by community nurses and disease 
intervention specialists from the HIV, syphilis and TB 
clinics at the county health department. Of 247 commu-
nity participants screened by the study, 240 had valid 
HIV test results. Prevalence of HIV in hotspot areas was 
compared with that among patients presenting to a sexu-
ally transmitted disease (STD) clinic located outside of 
the hotspot areas. HIV prevalence was higher among 
community screened participants (8/240, 3%, 95% CI 
1.4% to 6.5%) compared with the Wake County STD 
clinic (64/15 936, 0.4%, 95% CI 0.3% to 0.5%) with a risk 
ratio of 8.3 (95% CI 4.0 to 17.1, p<0.001). Community 
HIV screening identified eight HIV positive cases, only 
one of whom was previously undiagnosed.
spatially targeted tb interventions
In Moonan et al,24 notified TB cases from 1 January 
1993 to 31 December 2000 (N=991) were geolocated to 
zip codes in Tarrant County, north- central Texas, USA. 
Three zip codes were found to have the highest TB notifi-
cation rates per 100 000 of the population, in addition to 
having genotypically clustered Mycobacterium tuberculosis 
isolates.24 The TB notification rates of the zip codes were 
94, 55 and 32 cases per 100 000 while the case notification 
rate for the whole county for the same period was 5.9 cases 
per 100 000; 95 of 117 (81%) isolates were genotypically 
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clustered in these three zip codes.30 Between 1 September 
2002 and 31 December 2004 community- based organisa-
tions offered screening for TB and latent TB infection 
(LTBI) to hotspot residents. Overall, 3645 individuals 
were screened. 1.2% (N=44) people were diagnosed and 
treated for active TB, and 18.6% (N=681) were diagnosed 
and treated for LTBI. This targeted screening identified 
one person with active TB for every 83 screened, and one 
person with LTBI for every five screened. The yield of the 
targeted approach was considered to be more than what 
would be expected in a county with an active TB notifica-
tion rate of 5.7 per 100 000 population year.
Goswami et al29 (see above in HIV section) also offered 
screening for LTBI to the same individuals who were 
offered HIV testing. Both tests were performed from the 
same blood sample. Hotspot prevalence was compared 
with LTBI prevalence at the Wake County TB clinic, which 
was outside of the hotspot areas. Latent TB testing at the 
TB clinic was offered to high risk individuals who had 
close contact with a recently diagnosed active TB cases, 
refugees and those referred by primary care providers 
or employers. 234/247 had valid LTBI screening results. 
LTBI prevalence was higher among community screened 
participants (36/234, 15%, 95% CI 11.0% to 21.7%) 
versus 6% (95% CI 5.6% to 6.6%) at the TB clinic with a 
risk ratio of 2.5 (95% CI 1.9 to 3.5, p<0.001).
In Cegielski et al,31 notified TB cases in Smith County, 
Texas USA between 1985 to 1995 (N=128) and all notified 
LTBI cases from 1993 to 1995 (N=311) were geocoded to 
their households. The geocoded cases were loaded into 
geographical information systems software to produce 
a point map of both active TB and LTBI cases. The two 
densest neighbourhoods of TB and LTBI cases were iden-
tified visually from the map. In 1996, study field workers 
went door to door in these neighbourhoods and offered 
tuberculin skin testing (TST). Of 2258, 1236 had LTBI 
testing and received results, 229/1236 (18.5%) were 
TST positive and 147 received treatment. To assess the 
intervention, the notified TB cases from 1996 to 2006 
in Smith County were mapped to do a before and after 
intervention comparison. The TB notification rates in 
the targeted hotspots declined from 39.6 per 1 000 000 
people per year (95% CI 30.4 to 48.8) from 1985 to 1995 
to zero from 1996 to 2006 (p<0.001). While for the entire 
Smith County the TB notification rates reduced from 8.1 
per 1 000 000 people per year (95% CI 5.2 to 11.0) from 
1985 to 1995 to 3.7 per 100 000 people per year (95% CI 
1.2 to 6.1) from 1996 to 2006 (p<0.001).
spatially targeted leprosy interventions
In De Souza Dias et al,32 leprosy cases notified between 
1998 and 2002 (N=368) in the municipality of Mossoro, 
Rio Grande do Norte in Brazil were geocoded to house-
holds. The geocoded cases were used to create a density 
map with a radius of 100 m, and four neighbourhoods 
with the highest concentration of cases were identified 
as hotspots. Four active case finding (ACF) campaigns 
were conducted in these hotspots between March and 
September 2005. Study team members went door to 
door to identify people with symptoms of leprosy and 
referred them to the nearest primary health clinic. Five 
hundred twelve possible leprosy cases were referred, and 
104 leprosy cases were diagnosed. The cases identified 
through hotspot ACF represented 50% of the total cases 
diagnosed in the city in 2005. In addition, the case noti-
fication rate in 2005 was higher than in 2004; 9.34 per 
10 000 versus 5.16 per 10 000, respectively.
In Jim et al,33 in the state of Pohnpei in the Federated 
States of Micronesia, notified leprosy cases from 2002 to 
2006 (N=502) were geocoded to households, producing a 
point- density map of 1 mile radius; areas with the densest 
areas were identified for ACF. During 2007 to 2008, ACF 
teams undertook door to door visits and screened house-
hold members for leprosy. There was an eightfold state-
wide decrease in the number of households that were 
screened between 2007 and 2009, while the number of 
identified cases was similar to the prespatially targeted 
ACF campaign period of 2002–2006.
In Barreto et al,25 notified leprosy cases from the two 
municipalities of Castanhal and Oriximinal in the state of 
Para, Brazil from January 2004 to February 2010 (N=633) 
were geocoded to households. The notified leprosy cases 
were aggregated by census tract to calculate census case 
notification rates, and a spatially empirical case detec-
tion rate was used to smooth notification rates. Census 
tracts were classified into four categories, with the highest 
category assigned to areas with >40 cases per 100 000 
population. Kulldorff’s spatial scan statistic was used to 
define groups of hotspot census tracts with statistically 
higher than average notification rates. Two schools were 
selected: one within a hotspot and one from a census tract 
with ≥40 notified leprosy cases per 100 000 populations. 
At these schools, 134 students with a mean age of 10 years 
were screened and 11/134, 8.2% (95% CI 3.5% to 13.0%) 
were diagnosed with leprosy based on clinical signs and 
symptoms. The diagnostic yield in hotspot area schools 
was significantly higher than in students from randomly 
selected schools from eight municipalities in the state 
of Para in a cross- sectional study between 2009 to 2011: 
63/1592, 3.9% (95% CI 3.0% to 4.9%) with a risk ratio of 
2.1 (95% CI 1.1 to 3.8).
Malaria
In Srivastava et al,34 notified malaria cases between 
2000 and 2005 obtained from the State Department of 
Health in Madhya Predesh were aggregated at block 
and district level. Malaria hotspots were defined based 
on the percentage of malaria cases that had Plasmodium 
falciparum malaria of all notified cases from 2000 to 2005. 
Unspecified targeted malaria interventions in 2007 were 
evaluated for effectiveness by comparing overall number 
of confirmed cases notified in 2006 with those notified 
in 2007. Absolute numbers of notified cases decreased 
by 5.7% (95% CI 4.7% to 6.7%) from 96 042 in 2006 
(p<0.05).
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In Herdiana et al,35 in Sabang island, Indonesia, docu-
mented malaria cases from 2007 to 2008 and self- reported 
malaria cases identified during a survey (N=319), were 
geocoded to households to produce point maps that 
classified 14 out of 18 villages as hotspots, based on 
absolute number of cases. From May 2010, home visits 
were conducted twice a month in hotspot villages, and 
only once in non- hotspot villages. Malaria blood smears 
were taken from anyone with current or recent history of 
fever, with smear- positive participants referred for treat-
ment. Household contacts and neighbours within 500 m 
of smear- positive participants were also screened. Inter-
ventions in hotspot areas included: improving malaria 
diagnostic labs, introduction of Artemisinin- based 
Combination Therapy for malaria treatment, scale- up of 
indoor residual spraying (IRS) and distribution of long- 
lasting insecticide- treated nets (LLINs). The incidence of 
malaria in hotspot areas decreased by 30- fold from 3.18 to 
0.13 per 1000 population from 2008 to 2011.34–36
In Bousema et al,36 between June and July 2011 in 
Rachuonyo, western Kenya, 17 503 individuals were 
screened for a malaria prevalence survey, including P. 
falciparum antibodies. SaTScan software was used to 
define hotspots based on the prevalence of antibody- 
positivity and age- adjusted antibody density. In total 27 
hotspots were identified. A randomised controlled trial 
randomly allocated ten hotspots 1:1 to either interven-
tion or control. The intervention activities were weekly 
larviciding of stagnant water bodies, provision of LLINs, 
IRS and mass drug administration (MDA). MDA was only 
administered to households that had a confirmed malaria 
case; febrile individuals (temperature >37.5°C) and chil-
dren aged 6 months–15 years were offered malaria rapid 
diagnostic tests. The following standard interventions 
were available to both arms, hotspots and evaluation 
zones (the area 500 m around each hotspot): annual IRS, 
case management at health facilities and distribution of 
LLINs from antenatal clinics.
There was no statistically significant difference in para-
site prevalence in evaluation zones (area around the 
hotspot) at 8 weeks and 16 weeks postintervention time 
points. The first evaluation zone (1–249 m) at the eighth 
week found 3.6% (95% CI −2.6% to 9.7%, p=0.216) and 
the second evaluation zone (250–500 m) at the eighth 
week 3.8% (95% CI −2.4% to 10.0%, p=0.187). Neither 
was there any significant difference in the first evalua-
tion zone (1–249 m) at the 16th week: 1.0% (95% CI 
−7.0% to 9.1%, p=0.713) and the second evaluation zone 
(250–500 m) at 16th week: 1.0% (95% CI −8.3% to 10.4%, 
p=0.809).
Influence of study quality on results
The risk of bias assessment of the studies in this review 
focused on how the hotspots were selected and how the 
intervention were assessed in each of the studies that 
were included. The studies in this review were found 
to have issues that would make them susceptible to risk 
of bias. Hotspot selection was based mainly on notified 
cases.24 25 29 32–35 37 38 Relying on notified cases alone can 
introduce selection bias because notified cases can over- 
represent cases from areas that have good access to health 
systems.15
Further, identified geographical hotspots need to 
be investigated for stability overtime to ensure that 
they display spatio- temporal consistency in notification 
trends.15 39 This was not accounted for in the studies 
included in this review.24 25 29 32–38 40
The majority of the identified studies were implemen-
tation/pragmatic studies.24 25 29 31–35 40 41 These did not 
randomise hotspots to interventions and therefore the 
studies might have compared outcomes of the study in 




The key finding of this review is that, despite increasing 
enthusiasm for the application of spatially targeted inter-
ventions in public health research addressing infectious 
diseases,42 very few studies have rigorously evaluated the 
effectiveness of such approaches against non- hotspot 
comparator areas. We identified only 10 studies conducted 
since 1993, nearly all of which had substantial limitations 
in how hotspots were defined and identified, how spatially 
targeted interventions were evaluated, or how compar-
ator areas were selected. With the limited evidence avail-
able, we found some suggestion that hotspot- targeted 
interventions for TB, malaria and leprosy may be effi-
cient and effective approaches in increasing diagnostic 
yield, reducing unnecessary screening, and perhaps in 
improving disease epidemiology. However, almost all the 
studies were vulnerable to bias due to regression to the 
mean: hotspots identified by highest prevalence/inci-
dence will typically see prevalence/incidence decline, 
even in the absence of an intervention. As such, spatially 
targeted approaches hold promise, but require further 
evaluation in high- quality studies to guide policy- makers 
considering implementing this approach.
strengths and limitations
We found fewer studies than we anticipated, poten-
tially due to the challenges of collecting spatial data in 
developing countries where most areas do not yet have 
municipal address systems or subdistrict postal code 
systems.15 43 Our search strategy was designed to be inclu-
sive, and we did identify one previous systematic review of 
spatially targeted intervention for TB.44 However, for data 
synthesis we included only primary manuscript sources 
and ensured that studies included in the previous, more 
narrowly focused systematic review were also included 
here. Nevertheless, in recent years technologies for 
obtaining spatial data have improved, become cheaper 
and hence more widely available; consequently, the inclu-
sion of spatial data within epidemiological and surveil-
lance studies as a tool to identify disease hotspots has 
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become more common.42 In theory, this should enable 
disease control programmes to collect spatial data for iden-
tifying and targeting hotspots.42 43 Thus, in future, prior-
itising complete mapping of low income countries, with 
introduction of effective residential identification systems 
should be a major priority. This would allow some of the 
methods for geolocation of notified cases in the studies 
in this review, which used manual and labour intensive 
approaches that also had high potential for imprecision, 
to be replaced with more efficient approaches.33
Investment in national geospatial and surveillance 
tools that allow rapid, accurate and scalable geolocation 
of cases from within health facilities in settings that lack 
postal codes would greatly facilitate spatial mapping of 
areas of interest.45 Such tools would enable the identifica-
tion of hotspots at finer scale and limit the use of arbitrary 
blocks.34 One important concern about targeting inter-
ventions on the basis of case- notifications alone, however, 
would be the potential for ascertainment bias to further 
disadvantage underserved populations from which cases 
are already under- notified due to limited access to health 
services.46 For populations where this is likely, the ideal 
approach would be to investigate disease burden using 
prevalence surveys, or developing models that include 
data on geographical distribution of measures of poverty 
and health service access that can be then allow routine 
notification data to be adjusted to account for likely 
under- ascertainment.46
We report a wide variety of interventions in the studies 
included in this systematic review. For HIV,29 TB24 29 31 
and leprosy,25 32 33 studies tended to focus on commu-
nity screening interventions in suspected geographical 
hotspots. Malaria studies,34–36 however, were more focused 
on complex interventions that combined community 
screening and MDA, with environmental measures to 
address the vector, including larviciding of stagnant water 
bodies and IRS.
Despite the above reservations, the studies that we 
have identified demonstrate the feasibility of the spatially 
targeted approach to direct resources towards community- 
based interventions. For case- finding interventions or 
community screening, spatially targeted interventions 
are a compromise between tracing known contacts of 
infectious cases and ACF interventions across the entire 
general populations or subpopulation (ie, whole urban 
slums).47 One limitation of contact tracing is that it 
misses out cases that are unknown to the index case, and 
so will fail to identify cases arising from transmission to 
casual contacts outside of the household.48 49 Spatially 
targeted interventions become increasingly important 
for diseases that are approaching elimination, since these 
conditions predispose the disease cases to cluster into 
disease hotspots.13–19 Hence, spatially targeted interven-
tions can help the most successful control programmes 
to systematically identify and address residual disease 
hotspots.12 19 32 50Among all of the studies reviewed here, 
only one (Bousema et al36) was assessed as having low risk 
of bias. This was a malaria intervention that evaluated the 
impact of a spatially targeted intervention in predefined 
inner and outer regions of hotspots (evaluation zones). 
This study design allows the evaluation of how targeting 
the hotspots benefits the individuals that are in the hotspot 
as well as the individuals that are in the outer regions of 
the hotspot. This in turn allows assessment of the impact 
of the intervention on reducing transmission. For vector 
borne diseases, including malaria, consideration need to 
be given to the mobility of the vectors themselves when 
considering spatially targeted interventions51 that is, if 
mosquitoes are able to travel over moderate distances the 
effect of a hotspot targeted intervention might end up 
being diluted.
However, this study had several limitations.36 It was 
underpowered to detect small changes due to the hotspot 
targeted intervention. In addition, the intervention was 
also done in one transmission season which might not 
have been enough to interrupt the epidemic.36 The area 
of study might also not have been suitable for a hotspot 
targeted intervention because even though malaria was 
heterogeneous there might have been widespread trans-
mission of malaria going on in the non- hotspot areas; this 
might have meant that a non- targeted approach would 
have been more appropriate for this setting.52
Overall, our systematic review’s limitation was that the 
studies we identified were heterogeneous, and we were 
unable to do a meta- analysis as planned. Also, the studies’ 
methodological quality had challenges due to the lack of 
validation of disease hotspots and the lack of random allo-
cation of clusters to interventions. We also only included 
manuscripts in English due to resource limitations, and 
only four diseases were included. Despite these limita-
tions, we were able to show the potential that spatially 
targeted interventions have towards improving disease 
epidemiology.
recommendations
In general spatially targeted interventions are only 
justifiable in settings where the epidemic is heteroge-
nous and where the non- hotspot areas cannot sustain 
sufficient transmission of the disease.36 The influence 
of the hotspots on the epidemic of the disease in the 
surrounding communities also depends on the effec-
tive contact rates between the residents of the hotspots 
and the surrounding areas; in the case of malaria this 
also depends on how far mosquitoes can travel between 
the hotspots and the surrounding communities. Careful 
attention needs also to be given to identifying hotspots to 
make sure that the hotspots capture the true burden of 
the disease by making sure that the hotspots are persistent 
in time and are adjusted for confounding.51–53
COnClusIOn
The rapid increase in cheap, reliable, geolocation tech-
nology now provides such a significant tool in the fight to 
control and eradicate endemic and epidemic infectious 
diseases that support for rapid development of effective 
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patient mapping systems should be considered essen-
tial for health systems in low income countries. Ideally, 
mapping should be combined with statistical model-
ling to identify hotspots with the most pressing need 
for intervention. In this systematic review we provide 
some evidence in support of the effectiveness of spatially 
targeted intervention, but with the major conclusion 
being that the current body of evidence is weak. There is 
an urgent need to define optimal methodology, allowing 
recommendations to be made to support the design of 
more rigorous studies that allow clear evaluation of likely 
impact to be made for the major categories of infectious 
diseases, including vector- borne and those transmitted 
person- to- person. Recommendations should include 
strategies for timely identification of hotspots and the 
critical aspects needed to measure the effect of interven-
tion strategies targeting those hotspots.
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